Korsten Mark A, Spungen Ann M, Radulovic Miroslav, Rosman Alan S, Hunt Kristel, Galea Marinella D, Kornfeld Stephen D, Lyons Brian L, Yen Christina, Bauman William A
*National Center of Excellence for the Medical Consequences of Spinal Cord Injury †Medical Service ‡Spinal Cord Injury Service, James J. Peters VA Medical Center, Bronx Departments of §Medicine ∥Rehabilitation Medicine, The Icahn School of Medicine at Mount Sinai, New York, NY.
J Clin Gastroenterol. 2015 Oct;49(9):751-6. doi: 10.1097/MCG.0000000000000284.
Poor preparation for elective colonoscopy is exceedingly common in persons with spinal cord injury (SCI). This unsatisfactory outcome is likely due to long-standing difficulty with evacuation and decreased colonic motility, which may result in inadequate responses to conventional bowel preparation regimens. We determined whether the addition of neostigmine to MoviPrep before elective colonoscopy produced a higher percentage of acceptable bowel preparations in patients with SCI.
Twenty-seven SCI subjects were prospectively randomized to 1 of 2 arms: low-volume polyethylene glycol-electrolyte lavage with ascorbic acid (MoviPrep) or MoviPrep plus neostigmine methylsulfate and glycopyrrolate (MoviPrep+NG); 28 able-bodied subjects received MoviPrep alone. The quality of the cleansing preparation for colonoscopy was determined by gastroenterologists "calibrated" to use the Ottawa Scoring System, with an acceptable Ottawa Score (OS) considered to be ≤3.
The administration of MoviPrep alone resulted in suboptimal bowel cleansing in the SCI group compared with the able-bodied group (50% vs. 89% of subjects had an acceptable OS; χ=7.94, P=0.05). However, when NG was added to MoviPrep in the SCI group, it markedly improved the quality of the bowel preparation, with 85% of patients then having an acceptable OS. The use of NG resulted in minimal bloating and distention before bowel evacuation (P=0.0005), and eye and muscle twitching; these were resolved within 1 hour after NG administration. No significant differences were noted among the preparation groups for adenoma detection rate (P=0.41).
The combination of MoviPrep+NG was safe, well tolerated, and an effective approach to prepare the bowel for elective colonoscopy in patients with SCI. The side effects of this preparation were significant compared with the other treatment groups but were considered mild and anticipated.
在脊髓损伤(SCI)患者中,择期结肠镜检查准备不佳极为常见。这种不尽人意的结果可能是由于长期存在的排便困难和结肠动力下降,这可能导致对传统肠道准备方案的反应不足。我们确定在择期结肠镜检查前,在聚乙二醇电解质散(MoviPrep)中添加新斯的明是否能使SCI患者获得可接受的肠道准备的比例更高。
27名SCI受试者被前瞻性随机分为两组之一:低容量聚乙二醇电解质洗液加抗坏血酸(MoviPrep)或MoviPrep加甲硫酸新斯的明和格隆溴铵(MoviPrep+NG);28名身体健全的受试者仅接受MoviPrep。结肠镜检查清洁准备的质量由经“校准”使用渥太华评分系统的胃肠病学家确定,可接受的渥太华评分(OS)被认为≤3。
与身体健全的组相比,仅给予MoviPrep时,SCI组的肠道清洁效果欠佳(分别有50%和89% 的受试者OS可接受;χ=7.94,P=0.05)。然而,当SCI组在MoviPrep中添加NG时,肠道准备质量显著改善,85% 的患者OS可接受。使用NG导致排便前腹胀和肠扩张程度降至最低(P=0.0005),并出现眼部和肌肉抽搐;这些在给予NG后1小时内消失。各准备组之间腺瘤检出率无显著差异(P=0.41)。
MoviPrep+NG联合使用安全、耐受性良好,是为SCI患者择期结肠镜检查进行肠道准备的有效方法。与其他治疗组相比,该准备方法的副作用较为明显,但被认为是轻微且可预期的。